Health
CHOP researchers identify key target responsible for treatment failure in patients with hemophilia A – News-Medical.Net
Researchers at Children’s Hospital of Philadelphia have identified a key target that may be responsible for treatment failure in about 30% of patients with hemophilia…
Researchers at Children’s Hospital of Philadelphia (CHOP) have identified a key target that may be responsible for treatment failure in about 30% of patients with hemophilia A. The target, known as B cell activating factor (BAFF), appears to promote antibodies against and inhibitors of the missing blood clotting factor that is given to these patients to control their bleeding episodes. The findings, published in the Journal of Clinical Investigation, raise the possibility of using anti-BAFF therapies,…
-
General19 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
Business23 hours agoWhy this ASX 200 tech stock could rise 20%
-
Noosa News23 hours agoToyah Cordingley’s accused killer ‘3.7 billion times more likely than not’ to have contributed to DNA sample near burial site, court told
-
Noosa News22 hours agoStruggling AFLW teams GWS, Collingwood and Gold Coast receive extra picks or list spots from league